PTE News and Press, PolarityTE Inc. From 07/24/20

These Penny Stocks Are Spiking On News Headlines Today Penny stock news is somewhat of a “go-to” for traders. What I mean by that is those searching for momentum often look for catalysts. One of the easiest catalysts to search for are headlines. While large-cap stocks might ...

Natuzzi (NYSE: NTZ ) +131%  on renewing its securitization facility. More news on: Natuzzi S.p.A., Miragen Therapeutics, Theratechnologies Inc., Stocks on the move, Read more ...

Nano cap PolarityTE (NASDAQ: PTE ) jumps  43%  premarket on robust volume in reaction to preliminary data from a  study  evaluating SkinTE, an autologous human cellular and tissue-based product, in patients with diabetic foot ulcers. More news on: PolarityTE, Inc., ...

Company to Host Conference Call with Study Chair on Monday, July 27 th at 4:30 pm ET PolarityTE, Inc. (Nasdaq: PTE) announced positive results from a protocol-specified interim analysis of the first 50 patients enrolled in a multi-center randomized controlled trial evaluating treatm...

Company to Host Conference Call with Study Chair on Monday, July 27 th at 4:30 pm ET PolarityTE, Inc. (Nasdaq: PTE) announced that data from a protocol-specified interim analysis of the first 50 patients enrolled in a multi-center randomized controlled trial (RCT) entitled “S...

Published Data Includes Pilot Study of SkinTE in Diabetic Foot Ulcers and 15-Patient Case Series PolarityTE, Inc. (Nasdaq: PTE) reports the recent publication of two peer-reviewed manuscripts involving the application of SkinTE in a pilot study of diabetic foot ulcers and a 15-patien...

PolarityTE, Inc. (PTE) Q1 2020 Earnings Conference Call May 11, 2020, 8:00 am ET Company Participants Rich Haerle - VP, IR David Seaburg - CEO Richard Hague - President & COO Jake Patterson - Interim CFO Nikolai Sopko - CSO & VP, R&D Conference Call Participant...

The following slide deck was published by PolarityTE, Inc. in conjunction with their 2020 Q1 earnings Read more ...

PolarityTE, Inc. (Nasdaq: PTE) , a biotechnology company developing regenerative tissue products and biomaterials, today reported financial results for the first calendar quarter of 2020. PolarityTE will host a conference call and webcast today, May 11, 2020 at 8:00 a.m. ET. Highlights ...

Axcella Health (NASDAQ: AXLA ) initiated with Buy rating and $10 (115% upside) price target at BTIG Research. More news on: Axcella Health Inc., Viking Therapeutics, Inc., Y-mAbs Therapeutics, Inc., Healthcare stocks news, Stocks on the move, Read more ...